Lobbens Eva S, Breydo Leonid, Skamris Thomas, Vestergaard Bente, Jäger Anna K, Jorgensen Lene, Uversky Vladimir, van de Weert Marco
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark.
Department of Molecular Medicine and Byrd Alzheimer Institute, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd, MDC 07, Tampa, FL 33612, USA.
Biochim Biophys Acta. 2016 Sep;1864(9):1160-1169. doi: 10.1016/j.bbapap.2016.06.009. Epub 2016 Jun 21.
The presence of Lewy bodies and Lewy neurites is a major pathological hallmark of Parkinson's disease and is hypothesized to be linked to disease development, although this is not yet conclusive. Lewy bodies and Lewy neurites primarily consist of fibrillated α-Synuclein; yet, there is no treatment available targeting stabilization of α-Synuclein in its native state. The aim of the present study was to investigate the inhibitory activity of an ethanolic extract of Geum urbanum against α-Synuclein fibrillation and examine the structural changes of α-Synuclein in the presence of the extract. The anti-fibrillation and anti-aggregation activities of the plant extract were monitored by thioflavin T fibrillation assays and size exclusion chromatography, while structural changes were followed by circular dichroism, Fourier transform infrared spectroscopy, intrinsic fluorescence, small angle X-ray scattering and electron microscopy. Since the extract is a complex mixture, structure-function relationships could not be determined. Under the experimental conditions investigated, Geum urbanum was found to inhibit α-Synuclein fibrillation in a concentration dependent way, and to partly disintegrate preformed α-Synuclein fibrils. Based on the structural changes of α-Synuclein in the presence of extract, we propose that Geum urbanum delays α-Synuclein fibrillation either by reducing the fibrillation ability of one or more of the aggregation prone intermediates or by directing α-Synuclein aggregation towards a non-fibrillar state. However, whether these alterations of the fibrillation pathway lead to less pathogenic species is yet to be determined.
路易小体和路易神经突的存在是帕金森病的主要病理标志,尽管尚未定论,但据推测与疾病发展有关。路易小体和路易神经突主要由纤维化的α-突触核蛋白组成;然而,目前尚无针对稳定天然状态下α-突触核蛋白的治疗方法。本研究的目的是研究城市水杨梅乙醇提取物对α-突触核蛋白纤维化的抑制活性,并检测提取物存在时α-突触核蛋白的结构变化。通过硫黄素T纤维化测定和尺寸排阻色谱法监测植物提取物的抗纤维化和抗聚集活性,同时通过圆二色性、傅里叶变换红外光谱、内源荧光、小角X射线散射和电子显微镜观察结构变化。由于提取物是一种复杂混合物,无法确定其结构-功能关系。在所研究的实验条件下,发现城市水杨梅以浓度依赖性方式抑制α-突触核蛋白纤维化,并部分分解预先形成的α-突触核蛋白纤维。基于提取物存在时α-突触核蛋白的结构变化,我们提出城市水杨梅通过降低一种或多种易于聚集的中间体的纤维化能力,或通过引导α-突触核蛋白聚集形成非纤维状态来延迟α-突触核蛋白纤维化。然而,这些纤维化途径的改变是否会导致致病性较低的物种还有待确定。